Healthcare Infection Control Practices Advisory Committee, 56614-56615 [2020-20183]
Download as PDF
<![CDATA[
56614
Federal Register / Vol. 85, No. 178 / Monday, September 14, 2020 / Notices
GENERAL SERVICES
ADMINISTRATION
[Notice MA–2020–07; Docket No. 2020–
0002, Sequence No. 20]
Request for Public Comment:
Methodologies To Identify Excess
Personal Property
General Services
Administration (GSA).
ACTION: Notice.
AGENCY:
GSA is seeking input on
methodologies to identify personal
property as excess. See the
SUPPLEMENTARY INFORMATION section
below for additional guidance.
DATES: Comments must be received on
or before November 13, 2020.
ADDRESSES: Submit comments
identified by ‘‘Notice–MA–2020–07,
Methodologies to Identify Excess
Personal Property’’ by any of the
following methods:
• Regulations.gov: https://
www.regulations.gov. Submit comments
via the Federal eRulemaking portal by
searching for Notice–MA–2020–07,
Methodologies to Identify Excess
Personal Property. Select the link
‘‘Comment Now’’ that corresponds with
‘‘Notice MA–2020–07, Methodologies to
Identify Excess Personal Property.’’
Follow the instructions provided on the
screen. Please include your name,
company name (if applicable), and
‘‘Notice–MA–2020–07, Methodologies
to Identify Excess Personal Property’’ on
your attached document.
FOR FURTHER INFORMATION CONTACT: Mr.
William Garrett, Director, Personal
Property, Office of Government-wide
Policy, 202–368–8163 or via email at
william.garrett@gsa.gov.
SUPPLEMENTARY INFORMATION: In January
2018, the Federal Personal Property
Management Act (FPPMA), Public Law
115–419, was enacted requiring
agencies to regularly assess certain types
of personal property under their control
in accordance with guidance from GSA.
Subsequently, on December 20, 2019,
GAO published its final report GAO–
20–228, ‘‘Federal Property: GSA
Guidance Needed to Help Agencies
Identify Unneeded Property in
Warehouses.’’ The report concluded, in
part, ‘‘with the recent enactment of
FPPMA, an opportunity exists for GSA
to develop and communicate guidance
to help agencies assess property
utilization and identify unneeded
property in warehouses more efficiently
that includes practices GSA identifies as
being useful.’’ The report concluded
that the Administrator of General
Services should ‘‘direct the Office of
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:51 Sep 11, 2020
Jkt 250001
Government-wide Policy (1) to
incorporate into its guidance
approaches or practices that agencies
could use to assess utilization of and the
ongoing need for property—approaches
such as recommendations for periodic
justifications, data analytics, and
utilization reviews—and (2) to develop
a plan and timelines for communicating
the guidance to agencies governmentwide.’’ To address these
recommendations, in part, GSA
established a working group of Federal
and industry personal property
management experts. GSA is soliciting
input from the public to inform GSA
and the working group of existing
methodologies to effectively identify
excess personal property.
Although GSA may not respond to
each individual comment, GSA may
follow-up with respondents to clarify
input. GSA values public feedback and
will consider all comments that it
receives. GSA will also be conducting
targeted outreach on this same topic,
including engaging with subject matter
experts to improve internal guidance.
Jessica Salmoiraghi,
Associate Administrator, Office of the
Administrator.
[FR Doc. 2020–18209 Filed 9–11–20; 8:45 am]
BILLING CODE 6820–14–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Healthcare Infection Control Practices
Advisory Committee
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
AGENCY:
ACTION:
Notice of meeting.
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Healthcare Infection Control
Practices Advisory Committee
(HICPAC). This meeting is open to the
public, limited only by audio phone
lines available. The public is also
welcome to listen to the meeting by
dialing 1–877–924–1748, passcode:
6118574. A total of 200 lines will be
available. Registration is required. To
register for this call, please go to
www.cdc.gov/hicpac.
SUMMARY:
The meeting will be held on
November 5, 2020, from 9:00 a.m. to
3:00 p.m., EST.
DATES:
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
The teleconference access is
1–877–924–1748, and the passcode is
6118574.
FOR FURTHER INFORMATION CONTACT: KooWhang Chung, M.P.H., HICPAC,
Division of Healthcare Quality
Promotion, NCEZID, CDC, l600 Clifton
Road, NE, Mailstop H16–3, Atlanta,
Georgia 30329–4027, Telephone (404)
498–0730; Email: HICPAC@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Committee is charged
with providing advice and guidance to
the Director, Division of Healthcare
Quality Promotion (DHQP), the Director,
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
the Director, CDC, the Secretary, Health
and Human Services regarding 1) the
practice of healthcare infection
prevention and control; 2) strategies for
surveillance, prevention, and control of
infections, antimicrobial resistance, and
related events in settings where
healthcare is provided; and 3) periodic
updating of CDC guidelines and other
policy statements regarding prevention
of healthcare-associated infections and
healthcare-related conditions.
Matters To Be Considered: The agenda
will include updates from the following
HICPAC workgroups: The Healthcare
Personnel Guideline Workgroup; the
Long-term Care/Post-acute Care
Workgroup; and the Neonatal Intensive
Care Unit Workgroup. Agenda items are
subject to change as priorities dictate.
Procedure for Public Comment: Time
will be available for public comment.
Members of the public who wish to
provide public comments should plan
to attend the public comment session at
the start time listed. Please note that the
public comment period may end before
the time indicated, following the last
call for comments.
Procedure for Public Written
Comment: The public may submit
written comments in advance of the
meeting. Comments should be
submitted in writing by email to the
contact person listed above. The
deadline for receipt of written public
comment is October 21, 2020. All
requests must contain the name,
address, and organizational affiliation of
the speaker, as well as the topic being
addressed. Written comments should
not exceed one single-spaced typed page
in length. Written comments received in
advance of the meeting will be included
in the official record of the meeting.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
ADDRESSES:
E:\FR\FM\14SEN1.SGM
14SEN1
Federal Register / Vol. 85, No. 178 / Monday, September 14, 2020 / Notices
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–20183 Filed 9–11–20; 8:45 am]
BILLING CODE 4163–18–P
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–20184 Filed 9–11–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Healthcare Infection Control Practices
Advisory Committee; Notice of Charter
Amendment
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of charter amendment.
AGENCY:
This gives notice under (the
Federal Advisory Committee Act of
October 6, 1972, that the Healthcare
Infection Control Practices Advisory
Committee (HICPAC), Centers for
Disease Control and Prevention,
Department of Health and Human
Services, has amended their charter in
the Description of Duties and Agency or
Official to whom the Committee reports,
and sections throughout the document
as follows: (1) The Office of Infectious
Diseases (OID) has been renamed the
Deputy Director for Infectious Diseases
(DDID); (2) the Healthcare Facilities
Accreditation Program and the National
Association of Directors of Nursing
Administration as non-voting liaison
representatives have been removed; and
(3) the addition of non-voting liaisons
from the Organization for Safety,
Asepsis, and Prevention; the National
Rural Health Association; and the
Patient Safety Action Network; and the
addition of a non-voting ex officio
member from the Indian Health Service.
The amended filing date is August 28,
2020.
FOR FURTHER INFORMATION CONTACT:
Michael Bell, M.D., Designated Federal
Officer, HICPAC, Division of Healthcare
Quality Promotion, National Center for
Emerging and Zoonotic Infectious
Diseases, CDC, l600 Clifton Road, NE,
MS H16–3, Atlanta, Georgia 30329–
4027; Telephone: 404–639–4000; Email:
hicpac@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:51 Sep 11, 2020
Jkt 250001
Centers for Disease Control and
Prevention
[60Day–20–1227; Docket No. CDC–2020–
0097]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed revision to an information
collection project titled ‘‘Assessment of
Ill Worker Policies Study.’’ The study
will examine whether an educational
intervention has an effect on restaurants
either developing or expanding their ill
worker management policies.
DATES: CDC must receive written
comments on or before November 13,
2020.
SUMMARY:
You may submit comments,
identified by Docket No. CDC–2020–
0097 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
ADDRESSES:
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
56615
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7118; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
Assessment of Ill Worker Policies
Study (OMB Control No. 0920–1227,
Exp. 05/31/2021)—Revision—National
Center for Environmental Health
E:\FR\FM\14SEN1.SGM
14SEN1
]]>Agencies
[Federal Register Volume 85, Number 178 (Monday, September 14, 2020)]
[Notices]
[Pages 56614-56615]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-20183]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Healthcare Infection Control Practices Advisory Committee
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Healthcare Infection Control
Practices Advisory Committee (HICPAC). This meeting is open to the
public, limited only by audio phone lines available. The public is also
welcome to listen to the meeting by dialing 1-877-924-1748, passcode:
6118574. A total of 200 lines will be available. Registration is
required. To register for this call, please go to www.cdc.gov/hicpac.
DATES: The meeting will be held on November 5, 2020, from 9:00 a.m. to
3:00 p.m., EST.
ADDRESSES: The teleconference access is 1-877-924-1748, and the
passcode is 6118574.
FOR FURTHER INFORMATION CONTACT: Koo-Whang Chung, M.P.H., HICPAC,
Division of Healthcare Quality Promotion, NCEZID, CDC, l600 Clifton
Road, NE, Mailstop H16-3, Atlanta, Georgia 30329-4027, Telephone (404)
498-0730; Email: [email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The Committee is charged with providing advice and
guidance to the Director, Division of Healthcare Quality Promotion
(DHQP), the Director, National Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), the Director, CDC, the Secretary, Health
and Human Services regarding 1) the practice of healthcare infection
prevention and control; 2) strategies for surveillance, prevention, and
control of infections, antimicrobial resistance, and related events in
settings where healthcare is provided; and 3) periodic updating of CDC
guidelines and other policy statements regarding prevention of
healthcare-associated infections and healthcare-related conditions.
Matters To Be Considered: The agenda will include updates from the
following HICPAC workgroups: The Healthcare Personnel Guideline
Workgroup; the Long-term Care/Post-acute Care Workgroup; and the
Neonatal Intensive Care Unit Workgroup. Agenda items are subject to
change as priorities dictate.
Procedure for Public Comment: Time will be available for public
comment. Members of the public who wish to provide public comments
should plan to attend the public comment session at the start time
listed. Please note that the public comment period may end before the
time indicated, following the last call for comments.
Procedure for Public Written Comment: The public may submit written
comments in advance of the meeting. Comments should be submitted in
writing by email to the contact person listed above. The deadline for
receipt of written public comment is October 21, 2020. All requests
must contain the name, address, and organizational affiliation of the
speaker, as well as the topic being addressed. Written comments should
not exceed one single-spaced typed page in length. Written comments
received in advance of the meeting will be included in the official
record of the meeting.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to
[[Page 56615]]
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-20183 Filed 9-11-20; 8:45 am]
BILLING CODE 4163-18-P
